RET and medullary thyroid gland carcinoma: Notably, RET alterations play a role in the pathogenesis of PTC and MTC, with RET gene fusions that maintain the kinase domain identified as drivers of 10–20% of all PTCs, and activating somatic or germline RET mutations associated with the MTC subtype (17, 24, 25).